ALIT vs IBTA

The Advanced Deterministic Scorecard reveals a critically weak financial health with a Piotroski F-Score of just 2/9, indicating severe operational and profitability concerns. Despite a low Price/Book of 0.39 and a forward P/E of 2.56 suggesting deep value, the company is unprofitable with a staggering -94.23% profit margin and negative ROE of -66.86%. Revenue is declining YoY by 4%, and while recent EPS growth shows a sharp +185.7% YoY increase, this is from a negative base and inconsistent with long-term trends. The stock trades at a steep discount to the $5.07 analyst target, but fundamental deterioration, poor earnings execution (0/4 beats in last 4 quarters), and lack of Altman Z-Score data raise serious sustainability concerns.

IBTA exhibits significant valuation disconnects, trading at a massive premium to its Graham Number ($5.55) and Intrinsic Value ($0.84). While the Piotroski F-Score of 4/9 indicates stable financial health and the balance sheet is clean with very low debt (D/E 0.09), these are overshadowed by deteriorating fundamentals. Revenue growth is negative (-10% YoY) and earnings have collapsed (-87.2% YoY), suggesting the current price is speculative rather than data-driven.